On the role of the proform-conformation for processing and intracellular sorting of human cathepsin G

Blood. 1998 Aug 15;92(4):1415-22.

Abstract

The serine protease cathepsin G is synthesized during the promyelomonocytic stage of neutrophil and monocyte differentiation. After processing, including removal of an amino-terminal propeptide from the catalytically inactive proform, the active protease acquires a mature conformation and is stored in azurophil granules. To investigate the importance of the proform-conformation for targeting to granules, a cDNA encoding a double-mutant form of human preprocathepsin G lacking functional catalytic site and amino-terminal prodipeptide (CatG/Gly201/triangle upGly19Glu20) was constructed, because we were not able to stably express a mutant lacking only the propeptide. Transfection of the cDNA to the rat basophilic leukemia RBL-1 and the murine myeloblast-like 32D cl3 cell lines resulted in stable, protein-expressing clones. In contrast to wild-type proenzyme, CatG/Gly201/triangle upGly19Glu20 adopted a mature conformation cotranslationally, as judged by the early acquisition of affinity to the serine protease inhibitor aprotinin, appearing before the carboxyl-terminal processing and also in the presence of the Golgi-disrupting agent brefeldin A. The presence of a mature amino-terminus was confirmed by amino-terminal radiosequencing. As with wild-type proenzyme, CatG/Gly201/triangle upGly19Glu20 was proteolytically processed carboxyl-terminally and glycosylated with asparagine-linked carbohydrates that were converted into complex forms. Furthermore, it was targeted to granules, as determined by subcellular fractionation. Our results show that the initial proform-conformation is not critical for intracellular sorting of human cathepsin G. Moreover, we demonstrate that double-mutant cathepsin G can achieve a mature conformation before carboxyl-terminal processing of the proform.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Aprotinin / metabolism
  • Binding Sites
  • Biological Transport
  • Brefeldin A
  • COS Cells
  • Cathepsin G
  • Cathepsins / chemistry
  • Cathepsins / metabolism*
  • Cyclopentanes / pharmacology
  • Cytoplasmic Granules / metabolism*
  • DNA, Complementary / genetics
  • Enzyme Precursors / chemistry
  • Enzyme Precursors / metabolism*
  • Glycosylation
  • Golgi Apparatus / drug effects
  • Hematopoietic Stem Cells / metabolism
  • Hexosaminidases / pharmacology
  • Humans
  • Leukemia, Basophilic, Acute / pathology
  • Macrolides
  • Mice
  • Mutagenesis, Site-Directed
  • Protein Conformation*
  • Protein Folding
  • Protein Processing, Post-Translational
  • Rats
  • Recombinant Fusion Proteins / metabolism
  • Sequence Deletion
  • Serine Endopeptidases
  • Substrate Specificity
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Anti-Bacterial Agents
  • Cyclopentanes
  • DNA, Complementary
  • Enzyme Precursors
  • Macrolides
  • Recombinant Fusion Proteins
  • Brefeldin A
  • Aprotinin
  • Hexosaminidases
  • Cathepsins
  • Serine Endopeptidases
  • CTSG protein, human
  • Cathepsin G
  • Ctsg protein, mouse
  • Ctsg protein, rat